Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPSC-Derived Islet Cells in Diabetes Mellitus
NCT07464119Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial in diabetes mellitus (DM), sponsored by Peking University First Hospital. Primary endpoint: Adverse Events at 6 months. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07464119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07464119.